(a) Specifications.
Each tablet contains 1, 5, or 10 milligrams of butorphanol base activity as butorphanol tartrate.
(b) Sponsor.
See No. 000856 in § 510.600(c) of this chapter.
(c) Conditions of use.
The drug is used for the treatment of dogs as follows:
(1) Amount.
0.25 milligram of butorphanol base activity per pound of body weight.
(2) Indications for use.
For the relief of chronic nonproductive cough associated with tracheo-bronchitis, tracheitis, tonsillitis, laryngitis, and pharyngitis associated with inflammatory conditions of the upper respiratory tract.
(3) Limitations.
For oral use in dogs only. Repeat at intervals of 6 to 12 hours as required. If necessary, increase dose to a maximum of 0.5 milligram per pound of body weight. Treatment should not normally be required for longer than 7 days. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Code of Federal Regulations
[47 FR l4702, Apr. 6, 1982, as amended at 53 FR 27851, July 25, 1988]